THE EFFECT OF HEPATOCYTE CULTURE CONDITIONS ON CYTOCHROME-P-450 LINKED DRUG-METABOLIZING-ENZYMES

[1] Bissell D M, 1980, Ann N Y Acad Sci, V349, P85, DOI 10.1111/j.1749-6632.1980.tb29518.x

[2] BURKE MD, 1974, DRUG METAB DISPOS, V2, P583

[3] COON MJ, 1977, ACS SYM SER, V44, P46

[4] FRY JR, 1980, ARCH PHARM, V311, P85

[5] GREENLEE WF, 1978, J PHARMACOL EXP THER, V205, P596

[6] LAKE BG, 1979, DRUG METAB DISPOS, V7, P181

[7] LU AYH, 1980, PHARMACOL REV, V31, P277

[8] INHIBITION OF OXIDATIVE DRUG-METABOLISM IN MICROSOMES [J]. PHARMACOLOGY & THERAPEUTICS, 1980, 10 (03) : 515 - 535

[9] EVIDENCE THAT LIGAND FORMATION IS A MECHANISM UNDERLYING THE MAINTENANCE OF CYTOCHROME-P-450 IN RAT-LIVER CELL-CULTURE - POTENT MAINTENANCE BY METYRAPONE [J]. BIOCHEMICAL JOURNAL, 1980, 188 (03) : 937 - 939

[10] NUTRIENT IMBALANCE CAUSES THE LOSS OF CYTOCHROME-P-450 IN LIVER-CELL CULTURE - FORMULATION OF CULTURE MEDIA WHICH MAINTAIN CYTOCHROME-P-450 AT INVIVO CONCENTRATIONS [J]. BIOCHEMICAL PHARMACOLOGY, 1980, 29 (23) : 3215 - 3218

[1] Bissell D M, 1980, Ann N Y Acad Sci, V349, P85, DOI 10.1111/j.1749-6632.1980.tb29518.x

[2] BURKE MD, 1974, DRUG METAB DISPOS, V2, P583

[3] COON MJ, 1977, ACS SYM SER, V44, P46

[4] FRY JR, 1980, ARCH PHARM, V311, P85

[5] GREENLEE WF, 1978, J PHARMACOL EXP THER, V205, P596

[6] LAKE BG, 1979, DRUG METAB DISPOS, V7, P181

[7] LU AYH, 1980, PHARMACOL REV, V31, P277

[8] INHIBITION OF OXIDATIVE DRUG-METABOLISM IN MICROSOMES [J]. PHARMACOLOGY & THERAPEUTICS, 1980, 10 (03) : 515 - 535

[9] EVIDENCE THAT LIGAND FORMATION IS A MECHANISM UNDERLYING THE MAINTENANCE OF CYTOCHROME-P-450 IN RAT-LIVER CELL-CULTURE - POTENT MAINTENANCE BY METYRAPONE [J]. BIOCHEMICAL JOURNAL, 1980, 188 (03) : 937 - 939

[10] NUTRIENT IMBALANCE CAUSES THE LOSS OF CYTOCHROME-P-450 IN LIVER-CELL CULTURE - FORMULATION OF CULTURE MEDIA WHICH MAINTAIN CYTOCHROME-P-450 AT INVIVO CONCENTRATIONS [J]. BIOCHEMICAL PHARMACOLOGY, 1980, 29 (23) : 3215 - 3218